Is CHGCY or QYLD a better dividend investment in 2026?

CHGCY currently yields 2.99% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: QYLD offers higher current income.

What is the dividend yield difference between CHGCY and QYLD?

CHGCY has a forward dividend yield of 2.99% ($0.82/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 8.93 percentage points.

Home › Compare › CHGCY vs QYLD

CHGCY vs QYLD: Dividend Comparison 2026

CHGCY yields 2.99% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CHGCY wins by $405.80M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CHGCY

● Live price

2.99%

Share price

$27.52

Annual div

$0.82

5Y div CAGR

100%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$405.82M

Annual income

$381,294,826.82

Full CHGCY calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — CHGCY vs QYLD

📍 CHGCY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CHGCY	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CHGCY + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CHGCY pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CHGCY

Annual income on $10K today (after 15% tax)

$253.82/yr

After 10yr DRIP, annual income (after tax)

$324,100,602.80/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, CHGCY beats the other by $324,095,792.38/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CHGCY + QYLD for your $10,000?

CHGCY: 50%QYLD: 50%

100% QYLD50/50100% CHGCY

Portfolio after 10yr

$202.93M

Annual income

$190,650,243.07/yr

Blended yield

93.95%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CHGCY buys

QYLD buys

No recent congressional trades found for CHGCY or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCHGCYQYLD

Forward yield	2.99%	11.92% ✓
Annual dividend / share	$0.82	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	100% ✓	0%
Portfolio after 10y	$405.82M ✓	$25.4K
Annual income after 10y	$381,294,826.82 ✓	$5,659.31
Total dividends collected	$404.01M ✓	$27.1K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: CHGCY vs QYLD ($10,000, DRIP)

Year	CHGCY Portfolio	CHGCY Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$11,297	$597.22	$10,352	$1,192.36	+$945.00 → CHGCY
2	$13,349	$1,261.10	$10,830	$1,347.57	+$2.5K → CHGCY
3	$17,069	$2,785.33	$11,460	$1,539.07	+$5.6K → CHGCY
4	$24,921	$6,656.96	$12,275	$1,777.84	+$12.6K → CHGCY
5	$44,832	$18,166.72	$13,323	$2,078.95	+$31.5K → CHGCY
6	$109,057	$61,087.10	$14,667	$2,463.34	+$94.4K → CHGCY
7	$394,447	$277,755.94	$16,396	$2,960.57	+$378.1K → CHGCY
8	$2,299,836	$1,877,777.60	$18,631	$3,612.97	+$2.28M → CHGCY
9	$22,925,198	$20,464,373.86	$21,548	$4,482.15	+$22.90M → CHGCY
10	$405,824,789	$381,294,826.82	$25,398	$5,659.31	+$405.80M → CHGCY

CHGCY vs QYLD: Complete Analysis 2026

CHGCY — Stock

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda; osteoporosis, including Actemra, Edirol, and Bonviva; renal diseases consist of Mircera and Oxarol; and neurology/other diseases comprise Hemlibra, CellCept, and Enspryng. It has various development product candidates in the areas of oncology, bone and joint diseases, autoimmune diseases, renal diseases, neurology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances with Roche Group; and collaboration and joint research with academia. The company was founded in 1925 and is headquartered in Tokyo, Japan. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd.

Full CHGCY Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this CHGCY vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CHGCY vs SCHD CHGCY vs JEPI CHGCY vs O CHGCY vs KO CHGCY vs MAIN CHGCY vs XYLD CHGCY vs JEPQ CHGCY vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.